Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonghan Yu

Showing results (81-90 of 138) with videos related to

Pageof 14
Sort By:
Frontiers in Oncology|June 24, 2022
Improved Prediction of Survival Outcomes Using Residual Cancer Burden in Combination With Ki-67 in Breast Cancer Patients Underwent Neoadjuvant ChemotherapyJi-Yeon Kim, Jung Min Oh, Se Kyung Lee, et al.
Journal of Breast Cancer|December 8, 2022
Predicting the Response of Neoadjuvant Chemotherapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer With Axillary Lymph Node Metastasis by Multigene AssayJun-Hee Lee, Jai Min Ryu, Jee Hyun Ahn, et al.
Medical Oncology (Northwood, London, England)|May 14, 2017
Prognostic value of ABO blood types in young patients with breast cancer; a nationwide study in Korean Breast Cancer SocietySungmin Park, Ku Sang Kim, Jeong-Soo Kim, et al.
Annals of Surgical Oncology|December 10, 2022
Association of Fat Graft with Breast Cancer Recurrence in Implant-Based Reconstruction: Does the Timing Matter?Kyeong-Tae Lee, Ju Hee Kim, Byung-Joon Jeon, et al.
Breast Cancer (Tokyo, Japan)|February 17, 2024
Outcomes of whole breast radiation therapy in Asian breast cancer patients with prior cosmetic implantsNalee Kim, Won Kyung Cho, Won Park, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 22, 2026
Prognostic factors and the role of GnRHa in premenopausal HR+/HER2+ breast cancer achieving pathologic complete response after neoadjuvant chemotherapySu Min Lee, Seok Jin Nam, Seok Won Kim, et al.
Journal of Breast Cancer|August 5, 2021
Effect of Poloxamer-Based Thermo-Sensitive Sol-Gel Agent on Upper Limb Dysfunction after Axillary Lymph Node Dissection: A Double-Blind Randomized Clinical TrialHee Jun Choi, Jai Min Ryu, Byung Joo Chae, et al.
Cancer Research and Treatment|January 10, 2022
Real World Evidence of Neoadjuvant Docetaxel/Carboplatin/Trastuzumab/Pertuzumab (TCHP) in Patients with HER2-Positive Early or Locally Advanced Breast Cancer: A Single-Institutional Clinical ExperienceJi-Yeon Kim, Seok Jin Nam, Jeong Eon Lee, et al.
JCO Precision Oncology|January 14, 2026
Oncologic Outcomes by Pathogenic <i>BRCA</i> Mutation Status in Young Luminal Breast Cancer: A Propensity-Matched CohortWoong Ki Park, Seok Jin Nam, Seok Won Kim, et al.
Journal of Breast Cancer|July 3, 2018
Which Patients with Left Breast Cancer Should be Candidates for Heart-Sparing Radiotherapy?Won Kyung Cho, Won Park, Doo Ho Choi, et al.
Pageof 14

Showing results (81-90 of 138) with videos related to

Sort By:
Pageof 14
Frontiers in Oncology|June 24, 2022
Improved Prediction of Survival Outcomes Using Residual Cancer Burden in Combination With Ki-67 in Breast Cancer Patients Underwent Neoadjuvant ChemotherapyJi-Yeon Kim, Jung Min Oh, Se Kyung Lee, et al.
Journal of Breast Cancer|December 8, 2022
Predicting the Response of Neoadjuvant Chemotherapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer With Axillary Lymph Node Metastasis by Multigene AssayJun-Hee Lee, Jai Min Ryu, Jee Hyun Ahn, et al.
Medical Oncology (Northwood, London, England)|May 14, 2017
Prognostic value of ABO blood types in young patients with breast cancer; a nationwide study in Korean Breast Cancer SocietySungmin Park, Ku Sang Kim, Jeong-Soo Kim, et al.
Annals of Surgical Oncology|December 10, 2022
Association of Fat Graft with Breast Cancer Recurrence in Implant-Based Reconstruction: Does the Timing Matter?Kyeong-Tae Lee, Ju Hee Kim, Byung-Joon Jeon, et al.
Breast Cancer (Tokyo, Japan)|February 17, 2024
Outcomes of whole breast radiation therapy in Asian breast cancer patients with prior cosmetic implantsNalee Kim, Won Kyung Cho, Won Park, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 22, 2026
Prognostic factors and the role of GnRHa in premenopausal HR+/HER2+ breast cancer achieving pathologic complete response after neoadjuvant chemotherapySu Min Lee, Seok Jin Nam, Seok Won Kim, et al.
Journal of Breast Cancer|August 5, 2021
Effect of Poloxamer-Based Thermo-Sensitive Sol-Gel Agent on Upper Limb Dysfunction after Axillary Lymph Node Dissection: A Double-Blind Randomized Clinical TrialHee Jun Choi, Jai Min Ryu, Byung Joo Chae, et al.
Cancer Research and Treatment|January 10, 2022
Real World Evidence of Neoadjuvant Docetaxel/Carboplatin/Trastuzumab/Pertuzumab (TCHP) in Patients with HER2-Positive Early or Locally Advanced Breast Cancer: A Single-Institutional Clinical ExperienceJi-Yeon Kim, Seok Jin Nam, Jeong Eon Lee, et al.
JCO Precision Oncology|January 14, 2026
Oncologic Outcomes by Pathogenic <i>BRCA</i> Mutation Status in Young Luminal Breast Cancer: A Propensity-Matched CohortWoong Ki Park, Seok Jin Nam, Seok Won Kim, et al.
Journal of Breast Cancer|July 3, 2018
Which Patients with Left Breast Cancer Should be Candidates for Heart-Sparing Radiotherapy?Won Kyung Cho, Won Park, Doo Ho Choi, et al.
Pageof 14